Trial Site Detail

 

Drug:
PLX3397 (PLX108-01)
Trial:
Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Pennsylvania Oncology Hematology Associates

     
Philadelphia , PA 19106
USA

 

Principal Investigator:
 Arthur Staddon, MD
Contact:
 Jennifer King, RN jenniferking@pennoncology.com
Activation Status of this Site:
 Closed
Notes about this Site:
Pennsylvania Oncology Hematology Associates Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.